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Summary
Excess copper is highly toxic and forms part of the
host innate immune system’s antibacterial arsenal,
accumulating at sites of infection and acting within
macrophages to kill engulfed pathogens. We show for
the first time that a novel, horizontally gene transferred
copper resistance locus (copXL), uniquely associated
with the SCCmec elements of the highly virulent,
epidemic, community acquired methicillin resistant
Staphylococcus aureus (CA-MRSA) USA300, confers
copper hyper-resistance. These genes are additional
to existing core genome copper resistance mecha-
nisms, and are not found in typical S. aureus lineages,
but are increasingly identified in emerging pathogenic
isolates. Our data show that CopX, a putative P1B-3-
ATPase efflux transporter, and CopL, a novel lipopro-
tein, confer copper hyper-resistance compared to
typical S. aureus strains. The copXL genes form an
operon that is tightly repressed in low copper environ-
ments by the copper regulator CsoR. Significantly,
CopX and CopL are important for S. aureus USA300
intracellular survival within macrophages. Therefore,
the emergence of new S. aureus clones with the copXL
locus has significant implications for public health
because these genes confer increased resistance to
antibacterial copper toxicity, enhancing bacterial
fitness by altering S. aureus interaction with innate
immunity.
Introduction
New methicillin resistant Staphylococcus aureus (MRSA)
clones are emerging and circulating worldwide presenting
a new threat to human health. The reasons for the emer-
gence of these clones are currently unknown. S. aureus is
an opportunistic pathogen responsible for a range of minor
and life-threatening diseases (Sullivan et al., 1984; Tong
et al., 2015) and is considered by the World Health Organi-
sation to be one of the major multidrug resistant bacterial
health threats globally (WHO, 2017). Hospital-associated
(HA) MRSA are a leading cause of nosocomial infections
worldwide, predominantly infecting patients with reduced
immune function. However, the MRSA problem has been
exacerbated by the emergence and spread of community-
acquired (CA) MRSA, which can cause infections in
healthy humans with no previous exposure to healthcare
situations (Otto, 2013). CA-MRSA mainly causes severe
skin and soft tissue infections (SSTI; Johnson et al., 2007)
but can also cause invasive life-threatening infections, for
example necrotizing pneumonia (Francis et al., 2005).
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The CA-MRSA clone USA300 is epidemic in the United
States (Mediavilla et al., 2012). The success of USA300
has been attributed in part to increased expression of viru-
lence genes and the acquisition of several mobile genetic
elements (MGE) encoding genes that enhance USA300
colonization, virulence and environmental survival (Diep
et al., 2006). S. aureus USA300, and other CA-MRSA iso-
lates, also show increased resistance to innate immunity
and reduced clearance from healthy airways compared to
other S. aureus clinical isolates (Yajjala et al., 2016). This
has been attributed to elevated resistance to alveolar
macrophage-mediated intracellular killing, although the
exact mechanisms involved have not been established
(Yajjala et al., 2016).
The North American USA300 clone (USA300-NAE) has
spread globally (Glaser et al., 2016), and a Latin American
variant (USA300-SAE) is epidemic in South America
(Nimmo, 2012). Interestingly, phylogenetic analysis deter-
mined that USA300-NAE and USA300-SAE evolved from
a common ancestor, with individual parallel epidemics
emerging simultaneously (Planet et al., 2015). USA300-
SAE cases are now being reported in North America and
Europe (Dach et al., 2016; Planet et al., 2016) suggesting
that this clone is also spreading globally.
Both USA300 variants cause the same range of dis-
eases and have become the predominant epidemic clones.
Acquisition by horizontal gene transfer (HGT) of the argi-
nine catabolic mobile element (ACME; Thurlow et al.,
2013) was suggested to be key to the success of USA300-
NAE. However, USA300-SAE isolates do not encode
ACME but instead carry a novel MGE encoding putative
copper and mercury resistance (COMER) determinants
(Fig. 1; Planet et al., 2015). Across the ACME and COMER
elements of the USA300-NAE and USA300-SAE clades,
there are only two genes that are conserved,
SAUSA300_0078 and SAUSA300_0079, encoding a
putative efflux transporter and a putative lipoprotein respec-
tively (Fig. 1; Planet et al., 2015). Consequently we
hypothesized that this novel locus may play a role in copper
resistance, and potentially the enhanced fitness and suc-
cess of the USA300 lineage by increasing survival against
antimicrobial copper.
Copper is an essential nutrient as a cofactor for some
essential enzymes, but excess copper is highly toxic to
bacteria (Djoko et al., 2015). Copper accumulates at sites
of infection, where it plays a major role in innate immunity,
with the infected host using copper to kill invading microor-
ganisms (Beveridge et al., 1985; Fones and Preston,
2013; Chaturvedi and Henderson, 2014; Fu et al., 2014;
Johnson et al., 2015; Hyre et al., 2017). Importantly mac-
rophages, which are critical to innate immunity, protecting
the skin and respiratory tract (Malissen et al., 2014; Kopf
et al., 2015), use copper as an antibacterial mechanism by
actively importing it into the phagosome (White et al.,
2009; Johnson et al., 2015). Consequently pathogens
have mechanisms to counteract copper toxicity, mainly by
limiting the copper concentration in their cytoplasm through
efflux or sequestration, which are important for virulence in
a diverse range of bacterial pathogens in a variety of infec-
tion models (Schwan et al., 2005; Ward et al., 2010;
Shafeeq et al., 2011; Johnson et al., 2015; Hyre et al.,
2017; Ladomersky et al., 2017).
All S. aureus possess a conserved operon encoding a
P1B-1-type ATPase copper efflux transporter (copA) and a
copper chaperone protein (copZ) (Sitthisak et al., 2007;
Fig. 1A) encoded as part of the core genome. The role of
S. aureus CopA in virulence is unknown. Some HA-MRSA
(CC36 and CC22 lineages) also possess an additional
copper exporting ATPase belonging to the P1B-3 subtype,
designated copB, encoded on a plasmid that is either
freely-replicating or integrated into the genome (Fig. 1B;
Fig. 1. The structure of S. aureus copper resistance operons.
A. The archetypal S. aureus copAZ operon encoding copA,
a copper-translocating P-type ATPase and copZ, a copper
metallochaperone found in the core genome of all S. aureus
strains.
B. The S. aureus copBmco operon encoding a putative copper-
translocating P-type ATPase and a multicopper oxidase respectively
carried on a plasmid that can be either chromosomally integrated
or free replicating.
C. The location of the copX and copL genes, encoding a putative
copper-translocating P-type ATPase and a lipoprotein of unknown
function respectively, in different S. aureus lineages.
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Baker et al., 2011). The copXL genes encoded in both the
ACME and COMER elements are predicted to encode a
novel copper resistance locus encoding a putative P1B-3-
type ATPase (SAUSA300_0078; herein designated copX)
and a putative lipoprotein (SAUSA_0079, herein desig-
nated copL).
We have studied the function of this putative copper
resistance locus (copXL) and found that it confers copper
hyper-resistance and promotes survival of USA300 in
macrophages. S. aureus isolates carrying the copXL locus
showed significantly increased copper resistance relative
to strains with only the conserved copAZ operon. Cells of
isogenic mutants of S. aureus lacking copX showed
decreased resistance to copper, and cells lacking either
copX or copL showed increased copper accumulation,
suggesting that both genes play a role in copper efflux,
with CopX likely being a copper-specific efflux transporter.
Transcriptional analysis demonstrated that expression of
the copXL operon is induced by copper, and regulated by
the copper sensor CsoR, which specifically binds to the
promoters of both copAZ and copXL. Importantly, the
copXL locus also plays a key role in survival against killing
by macrophages, demonstrating the importance of copXL
for increased resistance of S. aureus USA300 to innate
immune defences.
Results
S. aureus USA300 encodes a novel copper resistance
locus
The copXL locus shares 99% DNA sequence identity
with a locus from coagulase negative Staphylococcus
species, suggesting it has recently been acquired by S.
aureus USA300 through HGT. In USA300-SAE, the copXL
genes are found in COMER, associated with the staphylo-
coccal cassette chromosome mec (SCCmec) element and
a multi-copper oxidase (mco), whereas in USA300-NAE
the copXL genes are directly adjacent to the SCCmec/
ACME element (Fig. 1C). Genome searches confirmed
that these genes are not found in typical S. aureus line-
ages such as methicillin sensitive S. aureus (MSSA).
However, there is increasing evidence that some other clin-
ical isolates have recently independently acquired copXL
genes with 99% DNA sequence identity to the USA300
copXL genes, e.g., human and livestock-associated
CC398 (Gomez-Sanz et al., 2014; Ward et al., 2014;
Fig. 1C), Western Australia MRSA-59 (Monecke et al.,
2015), and Irish healthcare associated ST779 (Kinnevey
et al., 2013), suggesting that there is currently a strong
selection for acquisition of these genes.
The CopX protein is a predicted P1B-3-type ATPase efflux
transporter (Fig. 2A; Odermatt et al., 1993; Mana-Capelli
et al., 2003; Meloni et al., 2014). CopX shares 36% identity
overall with the archetypal S. aureus CopA polypeptide
(Sitthisak et al., 2007) but shares 83% overall identity with
CopB, which is found only in the genomes of a subgroup
of S. aureus lineages (Baker et al., 2011; Fig. 1B). All three
proteins have the characteristic eight transmembrane
domains including the key CPX motif, a conserved E1-E2
ATPase domain and a carboxyl terminal haloacid
dehalogenase-like hydrolase domain. CopA has two amino
terminal ferredoxin–like, heavy metal associated (HMA)
domains and corresponding CxxC copper binding motifs,
whereas both CopX and CopB lack these domains, instead
possessing predicted intracellular amino-terminal histidine-
rich metal binding domains common to the P1B-3 subtype
of this protein family (Fig. 2A; Odermatt et al., 1993;
Fig. 2. Schematic of S. aureus CopA and CopX P1B-type ATPase
transporters showing conserved eight transmembrane domains,
phosphatase (A) domains and ATP binding/phosphorylation (N/P)
domain. CopA has 2 ferredoxin domains and CxxC copper binding
motifs, whereas CopX has a novel amino-terminal poly-His
sequence.
B. Alignment of CopB and CopX amino-terminal poly-His
sequences.
C. Predicted structural model of CopL. Modelling of the CopL
structure built with Swiss-Model based on 4MDW shows that
conserved His and Met residues form two spatial clusters which we
hypothesize form copper binding sites within the ‘horseshoe’
structure of the tandem DUF1541 domains. Protein backbone
structure is shown as a ribbon, and predicted ligands (Met5green,
His5blue) of putative copper binding sites (highlighted yellow) are
shown as sticks.
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Mana-Capelli et al., 2003; Meloni et al., 2014). Alignment
of CopX and the other S. aureus copper pumps that
excluded the N-terminal domains showed similar levels
of homology (37% identity to CopA, 86% identity to
CopB), whereas an alignment of just the His-rich
N-terminal domains of CopX and CopB showed just 59%
identity (Fig. 2B).
The CopL polypeptide is predicted to be a surface-
exposed lipoprotein that contains two novel tandem
domains of unknown function (DUF1541). Homologues of
CopL are highly conserved in Staphylococci spp. and are
also present in other Gram-positive bacteria found in
oceans, estuaries and soil but no CopL homologues have
been functionally characterized, and thus the functions of
these proteins and their domains are unknown. However,
in silico analysis identified homology (51% identity) to an
uncharacterized protein from Bacillus subtilis YdhK, whose
structure has been determined by X-ray crystallography
(PDB ID 4MDW). Modelling (SWISS-Model; Biasini et al.,
2014) of the S. aureus CopL structure based on YdhK
suggested that a number of conserved His and Met
residues may form two spatial clusters that could form
potential copper binding sites within the ‘horseshoe’
structure of the tandem DUF1541 domains (Fig. 2C).
To test the hypothesis that copXL is a novel copper
resistance locus, we measured the growth of several S.
aureus strains of various genotypes (copXL1 vs. copXL-)
in elevated concentrations of CuCl2 in the defined minimal
medium RPMI-A. Our data show that S. aureus strains
encoding a single chromosomal copy of the copXL locus,
in addition to the core genome conserved copAZ operon,
show copper hyper-resistance compared to typical S.
aureus strains (p 0.0001; Fig. 3A). The copXL1 strains,
MRSA USA300 JE2, the CC398 MRSA porcine isolate
078588D (DP; Ward et al., 2014) and the CC398 MRSA
human isolate 072736J (JH; Ward et al., 2014) all showed
a significant increase in growth in high copper compared to
S. aureus Newman (p 0.0001; Fig. 3A). S. aureus
Newman, which encodes only the core copAZ locus with
no additional copper resistance elements, has copper
resistance typical of the majority of S. aureus lineages
(Baker et al., 2011).
EMRSA-16 and ATCC12600 both encode the additional
copBmco locus, EMRSA-16 as a single copy on the chro-
mosome, whereas ATCC12600 encodes the copBmco
locus on a multicopy plasmid (Baker et al., 2011). The
difference in gene copy number is reflected in copper
resistance because ATCC12600, unlike EMRSA-16,
shows a significantly increased growth in 300–500 mM
copper compared to Newman (p 0.0001; Fig. 3A). Inter-
estingly, copper resistance of USA300 JE2, with its single
chromosomal copy of the copXL locus, is comparable to
ATCC12600, which possesses the copBmco locus on a
multicopy plasmid. While it is possible that other factors
may contribute to these phenotypes, these data suggest
that the copXL locus may be a more effective copper resis-
tance mechanism than a single copy of copA or copBmco.
It should be noted that all MRSA strains and the copper
hyper-resistant S. aureus ATCC12600 showed a growth
defect in low copper conditions compared to the methicillin
sensitive strain, S. aureus Newman (p 0.0001; Fig. 3A),
although whether this fitness cost is due to the presence of
these additional copper resistance loci or another,
unrelated factor is unclear.
The copXL locus confers hyper-copper resistance
To investigate the role of copXL in copper resistance,
S. aureus JE2 isogenic copX, copL, copA and copXA
insertion mutants were constructed using S. aureus JE2
transposon library mutants, as described previously (Bose
et al., 2013). All mutations were transduced to a clean JE2
background and all copper-related phenotypes were main-
tained after transduction and were similar to the original
transposon.
Our data show that mutation of the copX gene signifi-
cantly increases S. aureus JE2 sensitivity to copper in the
restricted medium RPMI-A, and in the rich complex
medium BHI (p 0.0001; Fig. 3B). Interestingly, the copL
mutant showed a significant copper-dependent growth
defect in RPMI-A (p0.0001; Fig. 3B) but showed only a
minimal growth defect in BHI (p5 0.06; Fig. 3B). Together
these demonstrate that CopX is not dependent on CopL to
function. Unexpectedly, the S. aureus USA300 JE2 copA
mutant did not show significantly increased copper
sensitivity in either media. The double copAX mutant, how-
ever, showed an increased sensitivity to copper compared
to the copX mutant demonstrating that CopA does play a
role in copper resistance in USA300, which is masked
by CopX activity. None of the mutants showed a growth
defect in the absence of added copper (Supporting
Information Fig. S1).
To confirm that copXL confers copper hyper-resistance
in USA300, the copX, copL and copAXmutants were com-
plemented by expression of a wild type copy of the copXL
locus controlled by its native promoter encoded on pMK4
(pcopXL). Growth phenotype analyses showed significant
complementation of the copX and copAX mutants in BHI,
formally demonstrating that copXL does indeed confer
copper hyper-resistance in USA300 (p 0.01, Fig. 3C).
However complementation of the copLmutant with pcopXL
appeared to increase the sensitivity of the copL mutant to
copper in BHI (Fig. 3C), and particularly RPMI-A (Fig. 3D,
p< 0.0001), suggesting that pcopXL can inhibit growth.
This growth inhibition is copper-dependent, because there
are no differences in growth between any of the strains in
BHI or RPMI-A in the absence of additional copper
(Supporting Information Fig. S1). Interestingly, the pcopXL
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plasmid also inhibited the growth of the copX and copAX
mutants in the restrictive medium RPMI-A because both
complemented mutants only showed a small increase in
growth in the presence of copper in RPMI-A (copAX
p 0.04, Fig. 3D), unlike in BHI.
The copX and copL genes are important for copper
efflux
To determine whether CopX functions as a copper efflux
transporter, the whole cell metal content of wild type JE2
and the copA and copX mutant strains were compared by
ICP-MS analysis of extracts from acid-digested cells after
culture in RPMI-A medium in the presence or absence of
subinhibitory 100 mM CuCl2, Fe2(SO4)3 or ZnCl2 (Fig. 3E).
As predicted the copX mutant contained significantly ele-
vated copper content relative to the JE2 parent control,
consistent with the hypothesis that S. aureus CopX is a
copper efflux protein (p 0.04; Fig. 3E). The cellular iron
or zinc content was unchanged in the copX mutant strain
(Fig. 3E), which correlates with our inability to detect any
phenotype of this mutant strain during growth analyses in
the presence of inhibitory concentrations of zinc, nickel,
manganese and iron (1–3 mM) (data not shown), sugges-
ting that CopX is a copper-specific resistance mechanism.
Surprisingly, the copA mutant showed no change in cellu-
lar copper even though CopA is a known copper efflux
protein, and has been shown to be essential for copper
resistance for S. aureus strains that lack accessory copper
resistance loci (Sitthisak et al., 2007; Fig. 3E). Thus, these
data indicate that CopX is a highly effective efflux mecha-
nism, and plays a major role in copper resistance in
USA300.
ICP-MS was also used to determine whether the novel
CopL protein has a role in copper efflux. Unexpectedly,
considering that CopL is a predicted surface-bound
lipoprotein, copper concentrations in the copL mutant
cells were also elevated (p 0.05, Fig. 3E) despite the
CopA and CopX efflux proteins both being functional in
the copL mutant, showing that CopL likely functions in
copper resistance and that CopX and CopL can act
independently.
The horizontally gene transferred copXL locus is
regulated by copper and CsoR
Copper regulation of gene expression in S. aureus is
mediated by the copper sensing transcriptional repressor
CsoR (Baker et al., 2011). To determine whether the
expression of copXL is regulated by copper and by CsoR
in S. aureus, quantitative reverse transcriptase PCR (qRT-
PCR) was used to compare the transcription of the copX
and copA genes in S. aureus JE2 and the JE2 csoR::UNR
transposon mutant strain, grown in RPMI-A with and
without subinhibitory 100 mM CuCl2 for 4 h. The JE2 csoR
mutant strain showed no growth defect in elevated copper
concentrations (data not shown), demonstrating that any
impact on gene expression in the csoR mutant is due to a
lack of CsoR repression. Analysis by qRT-PCR using inter-
genic copX and copL primers, showed that the two genes
are transcribed as a single transcript, and copL expression
paralleled copX expression when tested independently
(Supporting Information Fig. S2), confirming that the copX
and copL genes form a bi-cistronic operon.
The transcription of the copXL operon was regulated in a
similar manner to the core genome copA gene.
Transcription of copX was induced 17-fold, and copA 15-
fold by copper (Fig. 4; p 0.0001), with both genes being
repressed in low copper by CsoR, indicated by an 18-fold
and 13-fold increase in expression in the csoRmutant in the
absence of copper (Fig. 4; p 0.0001). Interestingly, both
copA and copXL expression still showed some induction by
copper in the csoR mutant, although only the copXL
transcript showed a significant increase compared to low
copper conditions (Fig. 4; p 0.01), suggesting that there is
additional positive copper regulation in S. aureus USA300.
To investigate why the copA mutant strain showed
negligible changes in copper efflux or growth, the transcrip-
tion of the copA and copX genes in the reciprocal copA and
copX mutants was assessed. Importantly, we detected a
40-fold copper-induced increase in copXL expression in the
copA mutant (Fig. 4; p 0.0001) compared to a 15-fold
induction in the JE2 wild type strain. However, there was no
reciprocal increase in copA expression in the copX mutant
(Fig. 4) relative to JE2 in the presence of copper. Induction
of copXL expression in the copA mutant presumably
Fig. 3. The effect of copper on the growth of S. aureus isolates encoding different putative copper resistance systems. Growth of (A) wild type
S. aureus strains Newman (copAZ), EMRSA-16 (copAZ; chromosomal encoded copBmco), ATCC12600 (copAZ; plasmid encoded copBmco),
JE2 (copAZ; copXL), 078588D (DP; copAZ; copXL) and 072736J (JH; copAZ; copXL) cultured in RPMI-A with 0, 300 and 500 mM CuCl2; (B)
JE2 and copA, copX, copL and copAX mutants in both RPMIA with 500 mM and BHI with 2mM CuCl2; (C) the copper mutants carrying the
pcopXL complementation plasmid in BHI with 2mM CuCl2 and (D) RPMI-A with 500 mM CuCl2. In each case, optical densities at 600 nm were
determined after 24 h of growth at 378C for 24 h in 5% (v/v) CO2. Error bars represent61 SEM of at least 3 independent biological repeats.
Significance of JE2 growth compared to other strains was determined with a two-way ANOVA test (*5 p 0.05, **5p 0.01,
***5p 0.0001). Dashed lines on graphs represent the starting optical density. (E) Whole cell metal content as determined by ICP-MS
analysis for (left) copper, (centre) zinc and (right) iron of JE2 and mutant cells of S. aureus cultured in RPMI-A in the absence (black bars) or
presence of an elevated but subinhibitory concentration (100 mM) of copper, zinc or iron respectively. Metal levels are shown as mean6SEM
from at least 3 independent biological repeats. (*5p 0.05, **5 p 0.01).
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explains why the copA mutant showed no growth defect in
high copper concentrations, because the increased expres-
sion of CopX could compensate for loss of CopA.
Transcription analysis showed that copL expression was
found to be decreased in the copX insertion mutant, how-
ever, the gene is still expressed (Supporting Information
Fig. S2). Additionally phenotypic analysis of a USA300
FPR3757 silent copX deletion mutation, which has a wild
type level of copL transcription, had a similar phenotype to
the copX insertion mutant, demonstrating that CopL is
expressed at a sufficient level in the copX insertion mutant
that its function is unaffected (Supporting Information
Figs. S1 and S2).
To determine why the complemented strains showed
growth inhibition in RPMI-A, transcription of copX was also
assessed in the complemented pcopXL copX insertion
mutant compared to wild type JE2. Surprisingly copX
expression was induced 37-fold in low copper and 88-fold
in this strain in the presence of copper compared to wild
type JE2 in the absence of copper (Supporting Information
Fig. S2). This substantial increase in copX expression
could potentially explain the observed inhibition of growth
in in the complemented strains in high copper.
CsoR directly binds to the copXL promoter to regulate
copper-dependent expression
Direct regulation of the copX and copL putative promoters
by binding of CsoR was tested by electrophoretic mobility
shift analysis (EMSA) (Fig. 5). Putative CsoR binding
sequences were identified in the promoters of copA
(ATACCtataGGGGGTAC) and copX (ATACCctggGTGGG
TAT), but there is no obvious binding motif in the 20 bp
intergenic region between copX and copL (Fig. 5A).
Recombinant CsoR was produced in Escherichia coli, puri-
fied to homogeneity by liquid chromatography, and used in
anaerobic assays to characterize its binding to 200 bp
DNA fragments containing the sequences upstream of
copA (PcopA), copX (PcopX) or copL (PcopL). As expected
(Liu et al., 2007; Smaldone and Helmann, 2007), metal-
free CsoR showed strong binding to the PCR product
encompassing the copA promoter, strongly retarding the
Fig. 4. CopXL operon is repressed in low copper conditions.
Transcription of copA and copXL was determined by qRT-PCR in
cells cultured in the presence or absence of subinhibitory CuCl2
(100 mM) during exponential growth in JE2, copA, copX and csoR
mutants. Relative expression was calculated as RQ using the DDCt
method, which normalizes expression in each strain against an
endogenous control gene (gyrB) and expresses the data relative to
a reference strain (JE2 in the absence of Cu; RQ51 represented
by the dashed line). Error bars represent61 SEM of 3 biological
repeats (each performed in technical triplicate). Significance of
expression in each strain compared to the reference, or between
strains of interest, was determined by 2-way ANOVA with Dunnett’s
multiple comparison test (*5 p 0.1, ***5p 0.0001).
Fig. 5. CsoR binds to the copX but not the copL promoter
sequence in vitro.
A. A schematic representing the position and sequence of the
proposed CsoR binding site in the promoter region of copX. EMSA
analysis was performed to test for binding of purified recombinant
CsoR protein to the promoter sequences of the copXL locus. PCR
products (200 bp) containing the sequences upstream of (B)
copA (PcopA), (C) left, copX (PcopX), and right, copL (PcopL), were
mixed with a PCR product of non-specific DNA sequence (nsDNA),
and probed for binding of purified recombinant (A and B) apo- and
(A only) Cu(I)-CsoR.
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migration of PcopA in a dose-dependent manner (Fig. 5B).
In contrast, this DNA binding was absent after anaerobic
incubation of CsoR with one equivalent of Cu(I) prior to
addition of DNA (Fig. 5B). A PCR product of the sequence
upstream of copX was also strongly retarded in its gel
migration by apo-CsoR (Fig. 5C), demonstrating specific
binding of CsoR to the copX promoter. Conversely, the
migration of a PCR product of the sequence upstream of
copL (encompassing the 3’ end of the copX gene and the
short intergenic region) showed no retardation (Fig. 5C),
demonstrating no binding of CsoR to a putative copL
promoter, confirming the qRT-PCR data (Supporting Infor-
mation Fig. S2) that the two genes are co-transcribed.
Therefore, expression of the copXL operon is repressed by
direct binding of CsoR to the binding motif in the promoter
upstream of copX under low copper conditions, and
becomes de-repressed under elevated copper conditions.
CopX plays a major role in USA300 macrophage
survival
S. aureus can survive phagocytic killing by macrophages
(Kubica et al., 2008) but a role for copper resistance in the
intracellular survival of S. aureus has not been described.
A mechanism of copper-enhanced bactericidal activity in
macrophages was previously reported by White and
colleagues (2009) whereby IFNg-activated upregulation of
the copper importer, CTR1, and intracellular trafficking of
the ATP7A transporter leads to enhanced killing of copper
sensitive E. coli mutants by macrophages. To investigate
the relevance of copXL- mediated copper hyper-resistance
to the ability of S. aureus to survive in macrophages,
IFNg-activated macrophage survival experiments were
performed. The levels of survival (CFU ml21) of intracellu-
lar USA300 JE2 and the mutant strains lacking copA,
copX or copL were compared 3 h after phagocytosis
(Fig. 6). There was no difference in uptake of the mutants
by macrophages as assessed by CFU at T0 (Supporting
Information Fig. S3). Intracellular numbers of the wild type
remained high at this time point contrasting with all of the
copper sensitive mutants, which showed reduced survival.
Both the copX and copL mutants showed a statistically sig-
nificant decrease in survival (Fig. 6; p 0.001), suggesting
an important role of the CopX copper exporter and CopL
lipoprotein in overcoming copper toxicity following macro-
phage phagocytosis (Fig. 6).
Discussion
In this study we demonstrate that the horizontally trans-
ferred copX and copL genes, confer copper hyper-
resistance, are repressed in low copper concentrations via
the core genome copper-dependent regulator CsoR, and
play a key role in S. aureus survival in macrophages.
The copXL genes are the only two genes common to the
ACME and COMER elements associated with the
SCCmec of both epidemic USA300-SAE and USA300-
NAE strains of S. aureus. Together, these data suggest
that the recent evolution and success of these epidemic
MRSAs could be due to possession of these additional
copper resistance genes, enhancing bacterial fitness both
in the environment and within the host, and thus increasing
the success of the USA300 lineage by increasing survival
against the antimicrobial toxicity of copper.
Our data suggest that CopX is a likely copper efflux
transporter of the P1B-3 type (Odermatt et al., 1993;
Mana-Capelli et al., 2003; Meloni et al., 2014) responsible
for S. aureus copper hyper-resistance as confirmed by
growth in both rich (BHI) and restrictive (RPMI-A) growth
conditions, and ICP-MS analysis. Complementation stud-
ies confirmed the role of CopX in USA300 copper hyper-
resistance in rich media. However, in more stressful condi-
tions such as the restricted RPMI-A medium, the pcopXL
complementing plasmid inhibited growth in the presence of
additional copper. This was also observed when the copX
deletion mutant was complemented with a plasmid carry-
ing copX only (Supporting Information Fig. S1). qRT-PCR
showed a large increase in expression of copX in the com-
plementing strains and yet over-expression of CopX is only
inhibitory in the presence of high copper concentrations,
suggesting that the cell cannot cope with large amounts of
CopX in excess copper for reasons that are unclear.
Fig. 6. Survival of S. aureus from intracellular killing by
macrophages. Mouse RAW264.7 macrophages were seeded at
2 3 106 per ml in DMEM into 24-well plates and activated with
mouse IFN-g and Cu2SO4 for 18 h. Bacteria were added at a
multiplicity of infection (MOI) of 10 in DMEM and co-incubated with
monolayers for 30 min. The monolayers were subsequently washed
and extracellular bacteria were killed by treatment with gentamycin
(200 mg ml21) and lysostaphin (100 mg ml21) for 30 min. To
quantify intracellular bacteria, monolayers were washed and lysed
with ice-cold water at time point 0 (T0) and after 3 h (T3). CFUs
were counted to determine numbers of viable bacteria. Bars
represent the mean percentage survival6SD for at least three
independent experiments. (**5 p 0.001).
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Interestingly, unlike CopX, the similar S. aureus CopB
P1B-3 type transporter only confers copper-hyper resis-
tance when expressed at very high levels due to there
being multiple copies on free-replicating plasmids (Baker
et al., 2011); unpublished data not shown). A single copy
of copXL in S. aureus JE2 shows equivalent copper hyper-
resistance to S. aureus ATCC12600, which has copB on a
multicopy plasmid. Our transcription data do not suggest
that expression of copXL is notably higher than that of the
single copy chromosomally encoded copA in wild type
USA300. Therefore, together our data suggest that
S. aureus CopX is likely a highly effective transporter, or
there are other copper-dependent factors involved.
The novel CopL lipoprotein is also important for copper
hyper-resistance, copper efflux and survival in macro-
phages. Homologues of this protein are found in many
commensals and environmental bacteria and yet its func-
tion is unknown. It is predicted that CopL is surface bound
and may bind copper via the tandem DUF1541 domains,
though this remains to be tested. Thus, CopL could act as
a surface-bound copper sink that interacts with CopX or
CopA. Alternatively CopL could act as a copper sensor
and regulate copper-dependent gene expression, thus
increasing resistance to copper, analogous to the E. coli
NlpE/CutF lipoprotein, which is proposed to induce expres-
sion of other genes involved in the adaptation to copper
through interaction with the CpxA-CpxR two-component
regulator system (Gupta et al., 1995).
Our data show that S. aureus strains that possess the
copXL genes show copper hyper-resistance compared to
S. aureus strains that do not. Importantly CopX and CopL
enhance intracellular survival in macrophages. This could
explain why USA300 shows increased fitness in lower lung
infection compared to hospital-associated (HA)-MRSA and
improved survival in alveolar macrophages (Yajjala et al.,
2016).
Importantly possession of the copXL locus is predicted
to confer a strong selective advantage during infection,
because copper is used as an antibacterial by the host
and plays an essential role in innate immunity, virulence
and colonization of the nasopharynx (Shafeeq et al., 2011;
Chatterjee and Otto, 2013; Fu et al., 2014; Johnson et al.,
2015; Hyre et al., 2017). Copper hyper-resistance will also
confer increased fitness clinically (Marcus et al., 2017) and
in the community because copper toxicity is increasingly
being exploited therapeutically as an antimicrobial.
Therefore, acquisition of the copXL genes may in part
explain the success of the S. aureus USA300 epidemic
strain in both North and South America.
In conclusion, this study shows that acquisition of the
copXL locus enhances S. aureus USA300 fitness due to
increased resistance to innate immunity. This has worrying
implications because S. aureus USA300 clones are
spreading globally (Glaser et al., 2016; Dach et al., 2016;
Planet et al., 2016), with emergences in Europe, Africa
and India (Schaumburg et al., 2014; Egyir et al., 2015;
Rajan et al., 2015). Consequently, our study shows the
importance of the impact of acquisition of additional copper
resistance mechanisms for pathogenic bacteria and the
subsequent risks to our health and well-being, and demon-
strates the need for surveillance and efforts to combat
copper resistance mechanisms.
Experimental procedures
Bacterial strains
All bacterial strains and Staphylococcus aureus mutants are
listed in Supporting Information Table S1. E. coli was cultured
in Luria broth (LB) and was handled and transformed using
standard protocols. S. aureus strains were plated onto Luria
agar (LA) and cultured statically at 378C in 5% (v/v) CO2, in
the chemically-defined growth medium RPMI 1640 (Sigma-
Aldrich) supplemented with an amino acids solution (Sigma-
Aldrich) to a final concentration of 2% (v/v), termed RPMI-A or
Brain Heart Infusion (BHI) or Tryptic soy agar (TSA). Media
were supplemented with tetracycline (5 mg ml21), chloram-
phenicol (10 mg ml21), ampicillin (100 mg ml21), kanamycin
(75 mg ml21), spectinomycin (1250 mg ml21) or erythromycin
(10 mg ml21) when required. For blue/white screening, 40 ml of
50 mg ml21 X-Gal was spread onto agar plates before
inoculation with bacteria.
Copper locus mutagenesis
The Nebraska Transposon Mutant Library (NTML) consists of
1920 defined mutants of non-essential genes in S. aureus
USA300 JE2 (Bose et al., 2013). JE2 transposon mutants
NE590, NE191, NE561 and NE1750 (copX, copL, copA and
csoR respectively) were transduced, using phage, into a clean
USA300 JE2 background to eliminate any secondary
mutations that may have been generated during library
construction. The large transposon insertion in each mutant
can be replaced with either an antibiotic selective marker or a
markerless cassette using a set of molecular tools, as
described by Bose and colleagues (2013). The transposon in
copX was replaced with a markerless cassette, in copL with
an aphA-3 kanamycin resistance gene, and in copA with an
aad9 spectinomycin resistance gene using the temperature
sensitive vectors pTNT, pKAN and pSPC respectively (Bose
et al., 2013), resulting in the production of new JE2 mutant
strains designated copX::TnT, copL::kanR and copA::specR.
The copA::specR mutation was also transduced into the copX
mutant to create the double copAX mutant. The pcopXL
complementation plasmid was constructed by cloning the
complete copXL coding sequence alongside 551 bp upstream
of copX, allowing transcription from the native promoter, into
the E. coli/S. aureus shuttle vector pMK4 (Sullivan et al.,
1984). Briefly, the copXL sequence was PCR amplified from
USA300 JE2 wildtype DNA using primers copX_F2 and
copL_R, which contained EcoRI and BamHI restriction sites
respectively. The resulting PCR product was digested and
ligated into pMK4 at these sites, transformed into S. aureus
Staphylococcus aureus copper resistance and innate immunity 9
VC 2018 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.,
Environmental Microbiology, 00, 00–00
strain RN4220 and subsequently phage transduced into each
recipient strain.
For construction of a clean deletion mutant of copX, the
temperature sensitive plasmid pIMAY that utilizes a secY
antisense counter-selection determinant for allelic replace-
ment was used (Monk et al., 2012; Monk and Foster, 2012).
Briefly, flanking regions of copX were amplified by PCR using
primer pairs OL961F/962R and OL963F/964R with S. aureus
FPR3757 genomic DNA as the template and PrimeStar Max
DNA polymerase (Takara). A ‘crossover’ PCR was done with
the primers OL961F and OL964R using the upstream and
downstream PCR products as templates. After subcloning
into pCR2.1 (Invitrogen), the fragment was cloned into
pIMAY using NotI and EcoRI restriction sites and the recom-
binant plasmid transformed into chemically competent E. coli
SA08B (Lucigen) (Monk et al., 2012). The plasmid was
isolated from E. coli, verified by sequencing and then electro-
porated into S. aureus FPR3757, which was plated onto TSA
plus Cm 10 lg ml21 and incubated at 288C. Transformants
were incubated on TSA plus Cm 10 lg ml21 at 378C to stimu-
late pIMAY chromosomal integration. Colonies free of
replicating plasmid were grown at 288C without Cm and then
plated onto TSA containing anhydrotetracycline 1 lg ml21 for
counter-selection. Resulting colonies that showed loss of Cm
resistance were screened by colony PCR for the absence of
copX. Putative mutants were validated by PCR amplification
of genomic DNA flanking the deletion and DNA sequencing
(Monk et al., 2012).
The pcopX complementation plasmid was constructed by
cloning a 2.2 kb fragment PCR product using primers 944F
and 947R, that contained copX and its predicted promoter
(–196 bp upstream from start codon) into the E. coli/
S. aureus shuttle vector pOS1, provided by Dr. V.J. Torres at
New York University School of Medicine. The amplified frag-
ment was cloned into the EcoRI and BamHI restriction sites
of pOS and then transformed into E. coli SA08B (Lucigen).
The plasmid was isolated from E. coli, verified by sequencing
and electroporated into the S. aureus FRP3757 copX dele-
tion strain. Transformants were selected with Cm 10 lg ml21.
The presence of copX was confirmed by colony PCR and
subsequent plasmid extraction and digestion with BamHI
and EcoRI.
Copper growth assay
Strains were incubated in 20 ml RPMI-A or BHI for 16 h at
378C and 5% (v/v) CO2. Cells were pelleted and
re-suspended in 1 ml of fresh RPMI-A or BHI and used to
inoculate fresh, prewarmed RPMI-A or BHI to an OD600nm of
0.05. Aliquots (10 ml) were taken and supplemented CuCl2
and grown for 24 h. Subinhibitory and toxic copper concentra-
tions were determined using OD600 as a measure of growth
after 24 h. For copper toxicity growth assays, RPMI-A was
supplemented with 500 lM CuCl2, while BHI was supple-
mented with 2 mM CuCl2. Control conditions without
additional copper were included in all experiments. Supple-
mentation with 100 lM was determined to be subinhibitory in
RPMI-A and used for subsequent experiments were subinhibi-
tory conditions were required.
Whole cell metal analysis by ICP-MS
Strains were incubated in RPMI-A for 16 h and then inoculated
into RPMI-A to an OD600nm of 0.05. Aliquots were made from
these subcultures and supplemented with 100 mM CuCl2,
Fe2(SO4)3 or ZnCl2 with a fourth aliquot prepared with no
metal supplementation. Samples were normalized to the
same OD600nm, harvested by centrifugation, and washed twice
in 50mM Tris, pH 7.5, 100 mM NaCl, 10 mM EDTA at 48C.
Washed pellets were stored at 2808C until use, then thawed
and digested with concentrated nitric acid (Merck) for 48 h.
Digests were centrifuged at 21 000 g for 20 min at 48C and the
supernatants were analysed for total metal content using
inductively coupled plasma mass spectrometry (ICP-MS;
Thermo x-series). Samples were diluted 10-fold in 2% nitric
acid containing 20 lg l21 platinum and silver as internal stand-
ards, and analysed (100 reads, 30 ms dwell, 3–5 channels,
0.02 atomic mass unit separation, in triplicate) for 56Fe, 65Cu,
66Zn, 107Ag and 195Pt in collision cell mode (3 ml min21 8% H2
in He collision gas), and metal concentrations determined by
comparison to matrix-matched elemental standard solutions.
RNA extraction
Strains were grown to mid-exponential phase in RPMI-A, with
and without 100 mM CuCl2. Bacteria were pelleted and re-
suspended in 1 ml PBS, and 200 ml of 19:1 ethanol:phenol was
added to preserve the RNA during storage. Bacteria were pel-
leted and lysed for 30 min at 378C in 200 ml TE buffer
containing 10 mg ml21 lysostaphin and 20 mg ml21 proteinase
K, before being homogenized in RLT buffer (Qiagen) containing
10 ml ml21 b-mercaptoethanol, using a MP Biomedical Fast
Prep Instrument and Lysing Matrix B tubes (MP Biomedicals).
RNA was purified from this lysate using a Qiagen RNeasy kit,
with both on column DNase treatment (Qiagen) and a subse-
quent TurboDNase step (Thermo Fisher) to ensure RNA purity.
All RNA samples were confirmed to be DNA-free using qPCR.
qRT-PCR
Total RNA (1 mg) was converted into cDNA using Superscript
IV VILO Master Mix reverse transcriptase (Invitrogen), and
from this 0.5 ng of cDNA was used per qPCR reaction. qPCR
was carried out using SYBR Green Master mix (Applied Bio-
systems) in a 7300 Fast System (Applied Biosystems)
following manufacturer’s instructions. Relative gene
expression for each of the sample genes (for primers and con-
centrations used see Supporting Information Table S2) was
normalized to the expression of the endogenous control gene
gyrB, and calculated in relation to expression of a calibrator
strain, JE2, without copper, using the DDCt method to calcu-
late RQ (2-DDCt) (Livak and Schmittgen, 2001). Results are the
product of 3 independent biological replicates, and samples
were run in technical triplicate within each experiment. Statisti-
cal significance was calculated using 2-way ANOVA with
Dunnett’s multiple comparison test.
Cloning, expression and purification of recombinant CsoR
The wild type csoR gene was amplified from S. aureus geno-
mic DNA by PCR using primers CsoR_F and CsoR_R
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(Supporting Information Table S2) and the PCR product
cloned into pGEM-T (Promega). An internal NdeI site was
removed through silent mutation (CAT to CAC in the His76
codon) using primers CsoR_NdeI-F and CsoR_NdeI-R (Sup-
porting Information Table S2), before subcloning of the insert
into NdeI/BamHI digested pET-29a (Novagen) to generate
pET29a-CsoR, confirmed by sequencing (GATC). E. coli
BL21 (kDE3) cells transformed with pET29a-CsoR were
cultured in LB at 378C and protein expression induced at
OD600 0.6 for 5 h at 308C with 1 mM isopropyl-b-D-L-
thiogalactopyranoside (IPTG). Cells were harvested by centri-
fugation (4000 g, 30 min, 48C), washed in 25 mM Tris, 10 mM
EDTA, pH 7.5 and lysed by sonication in 25 mM Tris, 15 mM
dithiothreitol (DTT), pH 8.5 containing protease inhibitor cock-
tail (Sigma). The lysate was clarified by centrifugation (48 000
g, 40 min, 48C), the supernatant filtered (0.45 mm) and diluted
sixfold in the same buffer, before purification on a 5 ml HiTrap
Q HP anion exchange (AEX) column (Ge Healthcare) using
an Akta fast performance liquid chromatography (FPLC) sys-
tem (GE Healthcare). Protein was eluted with a linear NaCl
gradient (0–1 M) over 10 column volumes (CV) and fractions
analysed by SDS-PAGE. Fractions identified by SDS-PAGE to
contain CsoR were pooled, diluted to 50 mM NaCl, and con-
centrated by heparin affinity chromatography (GE Healthcare)
eluted with 10 mM phosphate buffer, pH 7, 15 mM DTT, 1 M
NaCl. Protein was treated with 10 mM EDTA and 20 mM
Tris(2-carboxyethyl)phosphine (TCEP) at 48C overnight, and
resolved on a Superdex 75 16/600 gel filtration column (GE
Healthcare) in 25 mM Hepes, 200 mM NaCl, 15 mM DTT, pH
7.5. Resulting CsoR fractions were concentrated using 15 ml
a 3MWCO centrifugal filter device (Amicon), flash-frozen in
liquid nitrogen and stored at2808C.
EMSA
DNA regions (200 bp) upstream of copX, copL and copA
were amplified from S. aureus genomic DNA by PCR using
the relevant primer pairs (see Supporting Information
Table S2), cloned into pGEM-T, and confirmed by sequencing.
These (and empty pGEM-T for the control DNA) were used in
PCRs using M13 primers to produce DNA samples for each
operator/promoter region, which were purified (PCR clean-up
kit; Sigma). DTT was removed from recombinant CsoR in an
anaerobic ([O2]< 5 ppm) chamber (Belle Technology) by bind-
ing to a 1 ml AEX column and washing with 10 CV anaerobic
20 mM Hepes, pH 7.5, then eluting in this buffer with 1 M
NaCl. CsoR was quantified from absorbance at 280 nm using
an experimentally-determined (by amino acid analysis – Alta
Biosciences) extinction coefficient, (E280nm51490 M21 cm21),
and the 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) (Sigma)
assay for free thiols (Vita et al., 2015). Stock solutions
(100 mM) of Cu(I) were prepared as previously described
(Vita et al., 2015), and 1 mole equivalent was added to CsoR
anaerobically and incubated for 30 min at room temperature.
EMSA reactions contained 100 ng ml21 poly(dI-dC) (Sigma),
1 mM DTT, 0.4 mg ml21 bovine serum albumin (BSA), 100 nM
target DNA and 100 nM control DNA in 20 mM Hepes,
100 mM NaCl, pH 7.0. Apo- or Cu(I)-CsoR was added (0–100
mM), and the mixture equilibrated anaerobically for 30 minutes
at room temperature, before resolution on 6% (w/v) native
polyacrylamide gels (pre-electrophoresed for 15 min at 42 V)
for 60–80 min at 82 V. Gels were stained in 10% (v/v) SYBR
Safe (Invitrogen).
Macrophage survival assays
The RAW264.7 mouse macrophage cell-line was cultured in
DMEM 10% (v/v) FBS. Monolayers were prepared by seeding
2 3 106 cells per ml (500 ml per well) in 24-well plates, which
were then cultured for 24 h in serum-free DMEM supple-
mented with copper sulfate (20–40 mM) and mouse IFNÇ
(50 mg ml21, Gibco) for 18 h at 378C, 5% CO2. Immediately
before infection, RAW264.7 cells were washed with DMEM
alone. S. aureus strains were cultured statically in RPMI-1640
supplemented with 100 mM copper sulfate for 18 h at 378C,
5% CO2. Immediately before the experiment bacteria were
washed twice with DMEM and adjusted to an OD600  0.05
(ca. 2 3 107 CFU ml21) in DMEM and co-incubated with
monolayers for 30 min. The monolayers were washed and
extracellular bacteria killed by treatment with gentamicin
(200 mg ml21) & lysostaphin (100 mg ml21) for 30 min. Mono-
layers were washed with DMEM and then lysed with ice-cold
water at time point 0 (T0) and after additional 3 h incubation
(T3) to determine the survival rates (CFU ml21), lysates plated
on agar, and CFUs counted.
Statistical analysis
Data are summarized as standard error of the mean (SEM.)
and were analysed using GraphPad Prism version 6.04
(GraphPad Software, La Jolla, CA). ANOVA or t tests were
used to determine significance as appropriate.
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Supporting information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Table S1. Bacterial strains and plasmids used in this study.
Table S2. Primers used in this study.
Fig. S1. Growth of wild-type S. aureus JE2 and FRP with
that of the isogenic copper mutants and their complementa-
tion strains in both RPMI-A and BHI6 toxic concentration of
copper. In each case, optical densities at 600 nm were
determined after 24 h of growth at 378C for 24 h in 5% (v/v)
CO2. Error bars represent 61 SEM of 3 independent bio-
logical repeats. Significance of JE2 growth compared to
other strains was determined with a two-way ANOVA.
Dashed lines on graphs represent the starting optical den-
sity. There is no significant difference in growth of these
strains in the absence of copper in either medium.
Fig. S2. (A) A schematic representing the position and
sequence of the qRT-PCR amplicons used in the qRTPCR
analysis, in relation to the copXL operon. (B) Transcription
of copA, copX, copL and the intergenic region between
copX and copL (copXL) was determined by qRT-PCR in
cells cultured in the presence or absence of subinhibitory
CuCl2 (100 lM) during exponential growth in JE2, copA::s-
pec, copX::TnT and JE2 csoR::FNS. In addition, copX
expression was also measured in the USA300 strain
FPR3757 and copL expression in FRP3575 and isogenic
copX deletion mutant to show that copL transcription is
unaffected in this strain. Data are presented on a log10
scale to highlight decreased expression of copL in the copX
mutant. (C) Transcription of copX in JE2 and the copX
insertion mutant carrying the complementation construct
pcopXL. In each case, relative expression was calculated
as RQ using the DDCt method, which normalizes expres-
sion in each strain against an endogenous control gene
(gyrB) and expresses the data relative to a reference strain
(JE2 in the absence of Cu). Error bars represent 6 1 SEM
of 3 biological repeats (each performed in technical tripli-
cate). The dashed line represents the RQ of 1, which
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represents the baseline level of expression for the calibrator
strain JE2 grown without copper. Data are presented on a
log10 scale, and the dashed line at y5 1 indicates the
expression level in the reference strain. Significance of
expression in each strain compared to the reference was
determined by two-way ANOVA with Dunnett’s multiple
comparison test *5 p0.0001.
Fig. S3. Macrophage intracellular bacterial survival CFU
data. Mouse RAW264.7 macrophages were seeded at 2 3
106 per ml in DMEM into 24-well plates and activated with
mouse IFN-g and Cu2SO4 for 18 h. Bacteria were added at
a MOI of 10 in DMEM and co-incubated with monolayers
for 30 min. The monolayers were subsequently washed and
extracellular bacteria were killed by treatment with gentamy-
cin (200 lg ml21) and lysostaphin (100 lg ml21) for 30 min.
To quantify intracellular bacteria, monolayers were washed
and lysed with ice-cold water at time point 0 (T0) and after
3 h (T3). CFUs were counted to determine numbers of via-
ble bacteria. Bars represent the mean CFU/ml 6 SD for
three independent experiments.
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